Read the full post on the Duane Morris Life Sciences Law Blog.<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"On November 7, 2023, the Federal Trade Commission (\u201cFTC\u201d) announced that it had issued notice letters to 10 life sciences companies regarding 100 patents that the FTC contends are improperly listed in the Orange Book, the FDA\u2019s Approved Drug Products with Therapeutic Equivalence Evaluations. Read the full post on the Duane Morris Life Sciences Law … <\/p>\n
Continue reading “Companies Receive FTC Notices Alleging Improper Orange Book Listings”<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[43,42,40,34,35,13,17],"ppma_author":[5],"class_list":["post-113","post","type-post","status-publish","format-standard","hentry","category-general","tag-drug-approvals","tag-fda","tag-life-sciences","tag-orange-book","tag-patents","tag-sarah-olaughlin-kulik","tag-sean-mcconnell"],"authors":[{"term_id":5,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/comments?post=113"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/113\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/media?parent=113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/categories?post=113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/tags?post=113"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/ppma_author?post=113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}